Palumbo Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Sell
1,456
-30
-2% -$10.3K 0.11% 140
2026
Q1
$523K Buy
1,486
+10
+0.7% +$3.56K 0.13% 124
2025
Q4
$483K Buy
1,476
+87
+6% +$27.6K 0.12% 127
2025
Q3
$377K Sell
1,389
-51
-4% -$14.8K 0.12% 115
2025
Q2
$402K Sell
1,440
-61
-4% -$17.3K 0.12% 121
2025
Q1
$468K Buy
1,501
+122
+9% +$36K 0.16% 98
2024
Q4
$359K Buy
1,379
+43
+3% +$12.8K 0.13% 108
2024
Q3
$430K Buy
1,336
+12
+0.9% +$3.92K 0.17% 94
2024
Q2
$414K Buy
1,324
+25
+2% +$7.34K 0.17% 90
2024
Q1
$369K Buy
1,299
+10
+0.8% +$2.93K 0.17% 95
2023
Q4
$371K Buy
1,289
+218
+20% +$59.4K 0.19% 90
2023
Q3
$288K Buy
1,071
+2
+0.2% +$499 0.16% 89
2023
Q2
$237K Buy
+1,069
New +$248K 0.15% 93

Other funds holding AMGN

Palumbo Wealth Management's AMGN Position: Q2 2026 in Review

Palumbo Wealth Management reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $10.3K and leaving 1,456 shares worth $527K. The position accounts for 0.11% of the portfolio, ranked #140.

Palumbo Wealth Management first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Palumbo Wealth Management held 1,456 shares of Amgen worth $527K as of Q2 2026.
  • Palumbo Wealth Management sold 30 Amgen shares in Q2 2026, an estimated $10.3K.
  • Amgen made up 0.11% of Palumbo Wealth Management's portfolio in Q2 2026, its #140 holding.
  • Palumbo Wealth Management first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.